FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220943912> ?p ?o ?g. }

• W4220943912 endingPage "12" @default.
• W4220943912 startingPage "1" @default.
• W4220943912 abstract "Azithromycin (AZM) is one of the most common broad-spectrum antibiotics. However, drug resistance is increasing and combination therapy has attracted great attention. AZM is usually combined with traditional Chinese medicine (TCM) preparations with heat-clearing and detoxifying effects, including Kumu injection (KM) made from Picrasma quassioides (D. Don) Benn.The present study aimed to investigate synergistic antimicrobial and anti-inflammatory activities of KM plus AZM with the aim of understanding the mechanism of clinical efficacy of combination regimens.Seven common bacterial clinical isolates and LPS-induced RAW 264.7 cells were used for assay of in vitro potency. The minimum inhibitory concentration (MIC) was determined for each drug, followed by synergy testing through the checkerboard method and fractional inhibitory concentration index (FICI) for quantifying combined antibacterial effects. The rat model of Klebsiella pneumoniae-induced pneumonia was developed and subjected to various drug treatments, namely, AZM, KM, or AZM plus KM, intravenously administered at 75 mg/kg once a day for one week. The combination effects then were evaluated according to pharmacodynamics and pharmacokinetic assessments.KM-AZM combination synergistically inhibits in vitro growth of all the test standard strains except Pseudomonas aeruginosa and also the drug-resistant strains of Staphylococcus aureus, Streptococcus pneumoniae, Shigella dysenteriae, Klebsiella pneumoniae, and Escherichia coli. Despite an additive effect against NO, KM plus AZM at an equal dose could synergistically suppress overrelease of the inflammatory cytokines TNF-α and IL-6 by LPS-induced RAW 264.7 cells. The combination significantly inhibited the proliferation of K. pneumoniae in the rat lungs, mainly by inactivating MAPKs and NF-κB signaling pathways. KM-AZM combination caused a onefold increase in apparent distribution volume of AZM, along with a significant decrease of AZM level in the livers and heart for pharmacokinetics.KM-AZM combination displayed synergistic antibacterial and anti-inflammatory effects beneficial to the therapeutic potential against bacterial infection." @default.
• W4220943912 created "2022-04-03" @default.
• W4220943912 creator A5002059830 @default.
• W4220943912 creator A5003610889 @default.
• W4220943912 creator A5007862010 @default.
• W4220943912 creator A5018439995 @default.
• W4220943912 creator A5027974095 @default.
• W4220943912 creator A5061040624 @default.
• W4220943912 creator A5081765022 @default.
• W4220943912 date "2022-03-16" @default.
• W4220943912 modified "2023-10-18" @default.
• W4220943912 title "Combination Therapy with TCM Preparation Kumu Injection and Azithromycin against Bacterial Infection and Inflammation: In Vitro and In Vivo" @default.
• W4220943912 cites W2001978282 @default.
• W4220943912 cites W2025314483 @default.
• W4220943912 cites W2063539737 @default.
• W4220943912 cites W2077150739 @default.
• W4220943912 cites W2145439564 @default.
• W4220943912 cites W2286236296 @default.
• W4220943912 cites W2418728465 @default.
• W4220943912 cites W2548608509 @default.
• W4220943912 cites W2578877719 @default.
• W4220943912 cites W2743624175 @default.
• W4220943912 cites W2748508637 @default.
• W4220943912 cites W2807003860 @default.
• W4220943912 cites W2884119982 @default.
• W4220943912 cites W2887238932 @default.
• W4220943912 cites W2896377206 @default.
• W4220943912 cites W2915204262 @default.
• W4220943912 cites W2943894404 @default.
• W4220943912 cites W2945717288 @default.
• W4220943912 cites W2953285292 @default.
• W4220943912 cites W2955689151 @default.
• W4220943912 cites W2971334347 @default.
• W4220943912 cites W2979416990 @default.
• W4220943912 cites W2981797466 @default.
• W4220943912 cites W2996969218 @default.
• W4220943912 cites W3060255527 @default.
• W4220943912 cites W3080536009 @default.
• W4220943912 cites W3120549751 @default.
• W4220943912 cites W3132791256 @default.
• W4220943912 cites W3153526630 @default.
• W4220943912 doi "https://doi.org/10.1155/2022/8533005" @default.
• W4220943912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35341154" @default.
• W4220943912 hasPublicationYear "2022" @default.
• W4220943912 type Work @default.
• W4220943912 citedByCount "0" @default.
• W4220943912 crossrefType "journal-article" @default.
• W4220943912 hasAuthorship W4220943912A5002059830 @default.
• W4220943912 hasAuthorship W4220943912A5003610889 @default.
• W4220943912 hasAuthorship W4220943912A5007862010 @default.
• W4220943912 hasAuthorship W4220943912A5018439995 @default.
• W4220943912 hasAuthorship W4220943912A5027974095 @default.
• W4220943912 hasAuthorship W4220943912A5061040624 @default.
• W4220943912 hasAuthorship W4220943912A5081765022 @default.
• W4220943912 hasBestOaLocation W42209439121 @default.
• W4220943912 hasConcept C104317684 @default.
• W4220943912 hasConcept C150903083 @default.
• W4220943912 hasConcept C176947019 @default.
• W4220943912 hasConcept C185592680 @default.
• W4220943912 hasConcept C202751555 @default.
• W4220943912 hasConcept C207001950 @default.
• W4220943912 hasConcept C2776933286 @default.
• W4220943912 hasConcept C2777058267 @default.
• W4220943912 hasConcept C2778907293 @default.
• W4220943912 hasConcept C2779489039 @default.
• W4220943912 hasConcept C2781253189 @default.
• W4220943912 hasConcept C4937899 @default.
• W4220943912 hasConcept C501593827 @default.
• W4220943912 hasConcept C523546767 @default.
• W4220943912 hasConcept C54355233 @default.
• W4220943912 hasConcept C547475151 @default.
• W4220943912 hasConcept C55493867 @default.
• W4220943912 hasConcept C57992300 @default.
• W4220943912 hasConcept C71924100 @default.
• W4220943912 hasConcept C86803240 @default.
• W4220943912 hasConcept C89423630 @default.
• W4220943912 hasConcept C98274493 @default.
• W4220943912 hasConceptScore W4220943912C104317684 @default.
• W4220943912 hasConceptScore W4220943912C150903083 @default.
• W4220943912 hasConceptScore W4220943912C176947019 @default.
• W4220943912 hasConceptScore W4220943912C185592680 @default.
• W4220943912 hasConceptScore W4220943912C202751555 @default.
• W4220943912 hasConceptScore W4220943912C207001950 @default.
• W4220943912 hasConceptScore W4220943912C2776933286 @default.
• W4220943912 hasConceptScore W4220943912C2777058267 @default.
• W4220943912 hasConceptScore W4220943912C2778907293 @default.
• W4220943912 hasConceptScore W4220943912C2779489039 @default.
• W4220943912 hasConceptScore W4220943912C2781253189 @default.
• W4220943912 hasConceptScore W4220943912C4937899 @default.
• W4220943912 hasConceptScore W4220943912C501593827 @default.
• W4220943912 hasConceptScore W4220943912C523546767 @default.
• W4220943912 hasConceptScore W4220943912C54355233 @default.
• W4220943912 hasConceptScore W4220943912C547475151 @default.
• W4220943912 hasConceptScore W4220943912C55493867 @default.
• W4220943912 hasConceptScore W4220943912C57992300 @default.
• W4220943912 hasConceptScore W4220943912C71924100 @default.
• W4220943912 hasConceptScore W4220943912C86803240 @default.
• W4220943912 hasConceptScore W4220943912C89423630 @default.

• next